In addition to the upregulation of CB1R, multiple studies demonstrated that overactivity of iNOS in the lungs contributes to PF, suggesting that iNOS inhibition can provide therapeutic benefit (26–29). The gene discussed is NOS2; the disease is pemphigus foliaceus.